Literature DB >> 28863739

Response of Encapsulated Rat Pancreatic Islets to Hypoxia.

M de Groot1, T A Schuurs1, P P M Keizer1, S Fekken1, H G D Leuvenink1, R Van Schilfgaarde1.   

Abstract

Hypoxia contributes to encapsulated pancreatic islet graft failure. To gain insight into the mechanisms that lead to hypoxia-induced graft failure, encapsulated islet function, vitality, and cell replication were assessed after 2 and 5 days of hypoxic (1% O2) and normoxic (20% O2) culture. The mRNA expression levels of Bcl-2, Bax, inducible nitric oxide synthase (iNOS), and monocyte chemoattractant protein 1 (MCP-1) were assessed, as well as the amount of nitrite and MCP-1 in the culture medium. Hypoxia was associated with loss of encapsulated islet function and vitality, but not with an increase in islet cell replication. Loss of vitality was due to necrosis, and only modestly due to apoptosis. Hypoxia was not associated with changes in the Bcl-2/Bax mRNA ratio, but it did increase the expression of iNOS and MCP-1 mRNA. The increased mRNA levels were, however, not associated with elevated concentrations of nitrite nor with elevated levels of MCP-1 protein. The increased iNOS mRNA levels imply a role for NO in the completion of cell death by hypoxia. The increased MCP-1 mRNA levels suggest that encapsulated islets in vivo contribute to their own graft failure by attracting cytokine-producing macrophages. The discrepancy between iNOS mRNA and nitrite is explained by the longer half-life of NO during hypoxia. MCP-1 protein levels are underestimated as a consequence of the lower number of vital cells in combination with a higher proteolytic activity due to necrosis. Thus, strategies to eliminate hypoxia may not only improve islet function and vitality, but may also reduce the attraction of macrophages by encapsulated islets.

Entities:  

Keywords:  Cell death; Encapsulation; Hypoxia; Islets of Langerhans; Monocyte chemoattractant protein 1 (MCP-1); Replication

Year:  2003        PMID: 28863739     DOI: 10.3727/000000003771000219

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

Review 1.  Bioprinting an Artificial Pancreas for Type 1 Diabetes.

Authors:  Juewan Kim; Kyungwon Kang; Christopher J Drogemuller; Gordon G Wallace; P Toby Coates
Journal:  Curr Diab Rep       Date:  2019-07-04       Impact factor: 4.810

Review 2.  Integrating Additive Manufacturing Techniques to Improve Cell-Based Implants for the Treatment of Type 1 Diabetes.

Authors:  Robert P Accolla; Amberlyn M Simmons; Cherie L Stabler
Journal:  Adv Healthc Mater       Date:  2022-04-22       Impact factor: 11.092

Review 3.  The Influence of Microenvironment on Survival of Intraportal Transplanted Islets.

Authors:  Ling-Ling Yan; Li-Ping Ye; Ya-Hong Chen; Sai-Qin He; Chen-Yang Zhang; Xin-Li Mao; Shao-Wei Li
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

4.  Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetes.

Authors:  Genaro A Paredes-Juarez; Paul de Vos; Jeff W M Bulte
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-03-13

Review 5.  Redox-Dependent Inflammation in Islet Transplantation Rejection.

Authors:  Jessie M Barra; Hubert M Tse
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-23       Impact factor: 5.555

6.  Long-term viability and function of transplanted islets macroencapsulated at high density are achieved by enhanced oxygen supply.

Authors:  Yoav Evron; Clark K Colton; Barbara Ludwig; Gordon C Weir; Baruch Zimermann; Shiri Maimon; Tova Neufeld; Nurit Shalev; Tali Goldman; Assaf Leon; Karina Yavriyants; Noa Shabtay; Tania Rozenshtein; Dimitri Azarov; Amanda R DiIenno; Anja Steffen; Paul de Vos; Stefan R Bornstein; Uriel Barkai; Avi Rotem
Journal:  Sci Rep       Date:  2018-04-25       Impact factor: 4.379

7.  Development of a Bioartificial Vascular Pancreas.

Authors:  Edward X Han; Juan Wang; Mehmet Kural; Bo Jiang; Katherine L Leiby; Nazar Chowdhury; George Tellides; Richard G Kibbey; Jeffrey H Lawson; Laura E Niklason
Journal:  J Tissue Eng       Date:  2021-06-28       Impact factor: 7.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.